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ABSTRACT  
Objectives 
Although no clear evidence exists, many international guidelines advocate early term 
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delivery of small for gestational age (SGA) fetuses. The aim of this study was to determine 
whether a protocol that included monitoring SGA fetuses beyond 37 weeks affected 
perinatal and maternal outcomes. 
Methods 
The impact of the introduction in 2014 of a protocol for management of SGA, which 
included risk stratification with surveillance and expectant management after 37 weeks for 
lower risk babies (Group 2), was compared with the previous strategy, which 
recommended delivery at around 37 weeks (Group 1). Data from all referred SGA babies 
over a 39 month period were analyzed.  
Results 
In group 1 there were 138 SGA babies; in group 2 there were 143.  The mean gestation at 
delivery was 37+4 and 38+2 weeks respectively (p=0.04). The incidence of neonatal 
composite adverse outcomes was lower in Group 2 (9% v 22% v; p<0.01) as was neonatal 
NNU admission (13% v 42%; p<0.01). Induction of labour and caesarean section rates 
were lower, and vaginal delivery (83% v 60%; p<0.01) was higher in group 2. Most of the 
differences were due to delayed delivery of SGA babies that were stratified as low risk. 
Conclusions 
This study suggests that protocol-based management of SGA babies may improve 
outcomes and that identification of moderate SGA should not alone prompt delivery. 
Larger numbers are required to assess any impact on perinatal mortality. 
 
INTRODUCTION 
The small for gestational age (SGA) fetus is at increased risk of perinatal complications 
including stillbirth1-4. Its identification remains a cornerstone of antenatal care. Several 
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authors report improved outcomes of such babies if they are identified in utero, largely as 
result of expedited delivery5,6, although this is still debated7-9. The DIGITAT study10 and 
subsequent Cochrane review11 concluded that intervention did not alter perinatal outcomes, 
nor indeed caesarean section rates, but was underpowered to detect an impact on stillbirth 
rates. On this basis the current UK Guidelines recommend delivery at 37 weeks for all 
fetuses with an estimated fetal weight below the 10th centile even where the pregnancy is 
otherwise uncomplicated and fetal/placental Dopplers are normal12; US guidelines13 are 
less prescriptive and uncertainty surrounds the optimal management and timing of 
delivery14.   
A principal difficulty is that many SGA fetuses are merely constitutionally small and 
therefore probably not at increased risk; equally a fetus may have impaired growth or 
placental function (fetal growth restriction: FGR) but not have a fetal weight below the 
10th centile15-17. Curtailment of pregnancy three weeks before term should prevent later 
stillbirth, whether the fetus is SGA or not. However, this has to be compared to the risks of 
obstetric intervention, possibly increased infant mortality18 and potentially greater neonatal 
unit admission7 rate and even long term morbidity19,20. 
Recent data suggest that the risk of adverse outcome can be better determined using 
multiple factors including the cerebroplacental ratio (CPR)21 and that conservative 
management of SGA fetuses with normal parameters is reasonable22.  
Delivery at 37 weeks for SGA was recommended in our unit prior to 2014, when we 
introduced a protocol that included conservative management of SGA babies not 
considered FGR beyond 37 weeks. The aim of this study is to compare the impact of this 
protocol with historical data in order to determine the effects it had on the obstetric and 
perinatal outcomes of antenatally diagnosed SGA babies. 
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METHODS 
This is an impact study examining data collected over a 39-month period (January 2013-
April 2016). The study was conducted in the John Radcliffe Hospital, Oxford, UK, a large 
tertiary referral unit with > 8000 deliveries per annum. Throughout the time period, growth 
scanning was not routine and was performed according to risk factors and abdominal 
palpation. Eligible women were those referred to the Fetal Medicine Unit (FMU), with a 
singleton non-anomalous fetus antenatally diagnosed as small for gestational age (SGA) 
from 36+0 weeks of gestation, but with a normal umbilical artery Doppler pulsatility index 
(UmbA PI) prior to referral. Small for gestational age was defined as an estimated fetal 
weight (EFW) <10th centile using Hadlock charts23. 
Protocol-based management of SGA pregnancies was introduced in October 2014, with a 
dedicated clinic for those pregnancies. 
Group 1: Women referred to the FMU between January 2013 and September 2014, 
managed in an ad hoc manner according to clinicians’ preference, broadly based on the 
national guidelines (RCOG)12, which recommend delivery at 37 weeks. 
Group 2: Women referred from October 2014 to April 2016, managed in accordance with a 
protocol as follows:  
On the first appointment the gestational age (GA) was confirmed based on the first-
trimester crown-rump length (CRL); the maternal serum level of the PAPP-A and the 
second trimester Uterine Arteries Doppler (UtA) were reviewed where available. Blood 
pressure (BP) and urinalysis were also assessed. Ultrasound measurements were re-taken, 
the umbilical artery and middle cerebral artery pulsatility index measured and the cerebro-
placental ratio was calculated. 
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All examinations were performed by an experienced operator (MV or AC) using a Voluson 
E8 (GE Medical Systems, Zipf, Austria) machine, equipped with a 6-2-MHz linear curved-
array transducer. The liquor volume was assessed measuring the deepest vertical pool. The 
umbilical artery pulsatility index (UmbA-PI) was calculated from a free-floating portion of 
the umbilical cord. The middle cerebral artery pulsatility index (MCA-PI) was measured in 
a transverse view of the fetal head, at the level of its origin from the circle of Willis. The 
cerebro-placental ratio (CPR) was calculated as the ratio MCA-PI/UmbA-PI, and was 
considered abnormal when < 5th centile for gestational age24. Doppler recordings were 
performed in the absence of fetal movements and voluntary suspended maternal breathing. 
All pulsed Doppler parameters were recorded automatically from at least three consecutive 
waveforms, with the angle of insonation as close to 0° as possible, and always below 30°.  
Based on the EFW, Doppler measurement and risk factors, women were stratified and 
underwent a tailored follow up and timing of delivery according to the clinic protocol: 
Delivery, by induction of labour, was advised at 37+0 weeks and not before, in “high risk” 
babies, defined as EFW <3rd centile; or CPR <5th centile; or mean uterine artery PI at the 
anomaly scan was >95th centile25; or if the PAPP-A had been <0.3MoMs in the first 
trimester, or if there was pregnancy-induced hypertension (≥140/90). If the above risk 
factors were absent (“low risk” babies), the US scan was repeated in one week if the EFW 
was between the 3rd and 5th, or in two weeks if it was between the 5th and the 10th 
centile. Where the EFW was between the 5th and 10th centile, patients were advised to 
deliver by 40+0 weeks; when it was between the 5th and 10th centile delivery was 
recommended by 41+0 weeks.  
Ultrasound and pregnancy outcomes were compared between the two periods. Ultrasound 
data were collected retrospectively for Group 1 and prospectively for Group 2, via an 
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electronic database system (Viewpoint); these were merged with demographic, obstetric 
details and neonatal outcomes via electronic patients record systems (Cerner Millenium 
and Badger). The last evaluation, performed within one week of delivery, was considered 
for analysis.   
The primary outcome was a neonatal composite adverse outcome (NCAO) defined as the 
presence of at least one of the following conditions: intrauterine or neonatal death, Apgar < 
7 at 5 min, cord arterial pH < 7.10, hypoglycemia (blood glucose <2.5mmol/l), and 
ventilation or cooling. Secondary outcomes were: admission to the neonatal admission to 
the neonatal unit (NNU), gestational age at delivery, mode of delivery and caesarean 
section rates. Neonatal policy remain unchanged during the time period and there was no 
policy for automatic neonatal unit admission simply because of gestation or birthweight. 
Interventions and outcomes were compared between the two groups and according to the 
risk stratification described above. Categorical variables are presented by number and 
percentage. Continuous variables are presented by mean with standard deviation or median 
with interquartile range. The Chi-square or Fisher’s exact test was performed for 
categorical variables and odds ratios (OR) with 95% confidence intervals were calculated; 
the independent-samples t-test was used for continuous variables. Institutional review 
board approval was granted in September 2005 (05/Q1605/110) and updated on Feb.1, 
2017. 
 
RESULTS 
Study population 
Patient selection for analysis is summarized in Figure 1. During 39 months, 363 women 
attended the Fetal Medicine Unit at the John Radcliffe Hospital having had at least one 
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scan showing a non-anomalous fetus with an EFW < 10th centile for the gestational age at 
beyond 36 weeks: 185 (51%) between January 2013 and September 2014 and 178 (49%) 
between October 2014 and April 2016. These represented 1.6% and 1.8% respectively of 
the singleton pregnancies >36 weeks delivered during this time at the John Radcliffe 
Hospital. After exclusion of babies whose EFW was found to be >10th centile and those 
without follow up data, there were 138 (49%) pregnancies in Group 1 and 143 (51%) in 
Group 2. 
Maternal baseline characteristics are shown in Table 1. There were no significant 
differences between the two groups. There were also no significant differences in the 
incidence of risk factors for SGA. Ultrasound findings are summarised in Table 2. There 
were no significant differences between the two groups, although there was a trend towards 
a greater proportion of high risk babies in Group 1.  
Overall maternal pregnancy outcomes are shown in Table 3. Data are given as mean ± SD, 
n (%) or median (interquartile range). In Group 2, the gestational age was significantly 
higher than in Group 1 compared to group 2; the induction of labour and caesarean section 
rate was lower, and the vaginal delivery rate higher.   Overall neonatal outcomes are shown 
in Table 4. The birthweight was significantly higher in Group 2. Although no significant 
difference was observed between the two groups of neonates in terms of Apgar score, 
umbilical arterial pH and base-excess alone, the incidence of neonatal unit admission was 
higher, and the neonatal composite adverse outcome (NCAO) was more than twice as high 
in Group 1 as in Group 2.   
The odds ratios with 95% CI of the main maternal and neonatal outcomes for Group 2 with 
Group 1 as reference are shown in Figure 2. 
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In Table 5 the interventions and major outcomes are stratified according to the allocated 
risk level. High risk babies, probably FGR, with either EFW < 3rd centile, or CPR < 5th 
centile, or uterine arteries PI > 95th centile, or PAPP-A < 0.3MoMs, or maternal 
hypertension, encompassed 58.7% of babies in Group 1 and 48.3% of babies in Group 2.  
In low risk SGA babies, there was a small but significant increase in gestation, with a 
significant increase in spontaneous onset of labour and greater birthweight. The low 
incidence of the composite adverse outcome in these babies was not significantly altered 
but the neonatal unit admission rate was significantly reduced. In high risk SGA babies, 
there were largely non-significant decreases in intervention in Group 2, a higher mean 
birthweight and a significant decrease in the incidence of NNU admission and the 
composite adverse outcome.  
There was one intrauterine death (IUD) in each group. In group 1 an IUD occurred at 37+2 
weeks, which as diagnosed at the first FMU appointment. The birthweight was <3rd 
centile; in group 2 a fetal death occurred in a pregnancy first identified to be SGA at 38 
weeks. The EFW was on the 3rd centile and the CPR was abnormal. Elective caesarean 
section was booked, because of a previous caesarean section, but was delayed by three 
days. The IUD was diagnosed the day before planned delivery. 
 
 
 
DISCUSSION 
There is an increasing trend towards early term delivery of small for gestational age 
babies12,13. Term neonatal unit admission rates are increasing in many countries26; early 
term delivery, also increasing27 in an attempt to prevent stillbirth, may be a major risk 
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factor. Our data suggest that a prescriptive protocol for management, including risk 
stratification with conservative management for those considered at ‘low risk’, allows less 
intervention to be accompanied by less neonatal morbidity.  
The data suggests that for the time period of Group 1, prior to the protocol, some risk 
stratification was already occurring in that babies that would have been ‘lower risk’. They 
were not all being delivered, as at least UK guidelines recommend, at 37 weeks. Some of 
this is because they were identified until after 37 weeks. If they had been, the differences in 
intervention between the 2 groups would have been greater. Nevertheless, a more 
conservative protocol-based management allowed significantly more to reach 39 weeks, to 
labour spontaneously and when delivery was considered indicated, to not be delivered by 
caesarean section. This was followed by a considerable reduction in NNU admission, 
although no alteration in the composite outcome which, in these ‘low risk’ babies, was 
relatively rare. Although the numbers are too small to make conclusions about perinatal 
mortality, this does suggest that reduced intervention in SGA babies that are likely to be 
constitutionally small is reasonable and may even improve outcomes.  
In babies considered ‘high risk’, there are also improvements in neonatal outcomes. The 
data do not allow firm conclusions as to why, and it is possible that the babies in Group 1 
were simply more high risk. However, it was not that the incidence of detected SGA 
differed between the 2 groups: (1.6 and 1.8% respectively). These are in accordance with 
expectations: approximately 5% of our babies are <10th centile by Hadlock charts and 
detection rates of SGA in the UK are around 30%6. Indeed, the differences could also be 
related to the protocol which stipulated induction as opposed to caesarean, and not before 
37 weeks, even in these higher risk babies.  
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The intrauterine death in group 2 was in a baby whose condition was diagnosed late, but 
met criteria for expedited delivery. Thus, this IUD would have occurred even under the 
former protocol. This highlights the need for identification of SGA, and FGR among non-
SGA babies, which were not the intention of this protocol.  
Previous reports have shown variable or increased morbidity with earlier delivery7,9. This, 
particularly neonatal unit admission, is to be expected if SGA but otherwise healthy babies 
are delivered even mildly preterm. The risk stratification part of the protocol, attempting to 
differentiate between constitutionally small fetuses and FGR fetuses, was an adaptation of 
a published protocol28, although we delayed induction of labour to 41 weeks in babies 
considered at least risk. This was because a key aim of our protocol was to limit induction 
of labour, and the gestation window of 40-41 weeks is one where a large number of 
women should deliver spontaneously.  
Other risk factors that may help determine risk in SGA babies include uterine artery 
Doppler in the third trimester 29, abdominal circumference trajectory30 and maternal age31. 
Using these may further reduce the risk of serious adverse outcomes; ideally, modelling of 
independent risk factors would allow a risk assessment tool.  
Our data also suggest that the introduction of a protocol-based management may improve 
maternal outcomes. This is in contrast to the conservatively managed arm of DIGITAT10. 
Although routine induction of labour at 39 weeks has not been shown to increase 
intrapartum intervention in many RCTs of higher risk pregnancies, overall caesarean 
section rates are often very high32, and induction is not viewed well by women33.  
We acknowledge a number of limitations. As discussed, we cannot exclude the possibility, 
in the babies considered high risk, that, despite the similar demographics, incidence of risk 
factors and detection rate of SGA babies, the improved neonatal outcomes are because 
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Group I contained higher risk babies. This does not, however, prevent conclusions being 
drawn about the low risk babies.  It highlights the drawbacks of an impact study, but the 
RCT10 that has addressed early term delivery did not use a prescriptive risk stratification 
protocol like ours. Our findings are also limited by the retrospective nature of data 
collection, particularly in group 1, and the consequent missing outcomes. Finally, we are 
unable to draw conclusions about stillbirth and long term morbidity: to do this would 
require vast numbers. 
The potential benefit of early term labour delivery is the prevention of later stillbirth. 
Indeed, curtailment of a pregnancy at any gestation will prevent stillbirth beyond the 
gestation of delivery, so this outcome cannot be considered in isolation: at the very least, 
neonatal and infant mortality must be considered. Late-onset FGR is also associated with 
increased perinatal morbidity in the form of fetal distress, hypoglycaemia, seizures, 
behavioural problems, cerebral palsy and cardiovascular disease35-37.  There are, however, 
other potential risks, including increased neonatal unit admission7 and childhood 
morbidity19,20, and increased ‘medicalisation’. What is not clear is the respective roles of 
the gestation or birthweight and of the pregnancy characteristics associated with early term 
delivery. 
 
 
 
 
CONCLUSIONS 
The ACOG Practice Bulletin13 states: “Size alone is not an indication of a complication. As 
a result of this confusion, under-intervention and over-intervention can occur.” The 
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prevention of over-intervention will become even more important if, as has been 
recommended in the UK38, detection rates of SGA increase. This means risk stratification 
is essential and we show it is effective. Although our study was too small to demonstrate 
an effect on stillbirth, it is uncertain if a large reduction in near term stillbirth is achievable 
by routine delivery of small babies, even if they are identified. A version of the protocol 
we have described in all pregnancies might yet achieve this. 
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Legends 
 
 
Table 1: Demographic details. Group 1 : pre-SGA clinic population; Group 2: SGA clinic 
population. 
 
Table 2: Risk stratification of Groups.  Group 1: pre-SGA clinic population; Group 2: 
SGA clinic population; EFW: estimated fetal weight; CPR: cerebro-placental ratio; UtA: 
uterine arteries. 
 
Table 3: Maternal outcomes. Group 1: pre-SGA clinic population; Group 2: SGA clinic 
population; GA: gestational age; LSCS: lower segment caesarean section. 
 
Table 4: Neonatal outcomes. Group 1: pre-SGA clinic population; Group 2: SGA clinic 
population. Hypoglycaemia: blood glucose <2.5mmol/l; NNU: neonatal unit admission; 
NCAO: neonatal composite adverse outcome.  
 
Table 5: Major interventions and outcomes stratified according to risk categories 
Group 1: pre-SGA clinic population; Group 2: SGA clinic population. LSCS: low segment 
caesarean section; NNU: neonatal unit admission; NCAO: neonatal composite adverse 
outcome.  
 
Figure 1. Flow chart: multi-step process of patients selection for the analysis of the study 
groups. Group 1: pre-SGA clinic population; Group 2: SGA clinic population. 
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Table 1: Demographic details 
 Group 1 Group 2 P value
 n (%) / mean (SD) n (%) / mean (SD)
Total 138 143
Age 28.24 (5.76) 29.58 (5.76) 0.63
BMI  24.1 (5.69) 23.6 (4.5) 0.36
Nulliparous   69 (50) 69 (48) 0.16
Hypertensive disorders   11 (8.5) 11 (7.3) 0.70
Gestational diabetes   7 (5.7) 6 (4.3) 0.60
Smoking  16 (13.1) 26 (17.7) 0.23
Drug misuse  5 (4.1) 5 (3.6) 0.82
Previous SGA baby  20 (15.7) 34 (23.8) 0.10
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Table 2: Risk stratification of Groups   
 
 
 Group 1 Group 2 P value
 n (%) n (%)
Total 138 143
High Risk* 81 (58.7) 69 (48.3) 0.08
- EFW < 3rd  54 (39.1) 47 (32.9) 0.22
- CPR < 5th  30 (21.7) 25 (17.0) 0.18
- UtA mean PI > 95th ** 15/43 (35) 14/50 (28) 0.5
- PAPP-A < 0.3 MoMs 6 (4.3) 8 (5.6) 0.4
Low Risk 57 (41.3) 74 (51.7) 0.08
- 3rd < EFW < 5th c  30 (21.7) 36 (25.2) 0.5
- 5th < EFW < 10th c 27 (19.6) 38 (26.6) 0.17
 
  
 
* inclusion criteria not mutually exclusive 
** not all women had 2nd trimester uterine artery Dopplers 
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Table 3: Maternal outcomes 
 
 
Outcome Group 1 Group 2 OR (95% CI) P value 
 n (%) / med (IQR) n (%) / med (IQR)
Total 138 143
Vaginal delivery 83 (60.1) 118 (82.5) 3.13 (1.80-5.42) <0.01 
Instrumental deliver 15 (10.9) 17 (11.9) 1.11 (0.53-2.31) 0.79 
Labour Induction 91 (66) 77 (53.8) 0.60 (0.37-0.98) 0.04 
Elective LSCS 31 (22.5) 17 (11.9) 0.47 (0.24-0.89) 0.02 
Emergency LSCS   24 (17.4) 18 (12.6) 0.68 (0.35-1.33)  0.26 
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Table 4: Neonatal outcomes 
 
Outcome Group 1 Group 2 OR (95% CI) P value 
 n(%)/mean(SD) n(%)/mean(SD)
Total 138 143
Birthweight (g) 2328 (335) 2544 (337) <0.01 
Perinatal mortality   1 (0.7) 1 (0.7) 1.09 (0.07-17.67) 1.00
Gestation at delivery 37.4 (1,7) 38.2 (1,9) 0.04
Delivery >39 weeks 27 (19.6) 50 (35.0) 2.28 (1.33-3.94) <0.01 
Arterial pH < 7.1 4/51 (7.8) 1/47 (2) 0.26 (0.03 – 2.37) 0.36
Arterial pH  7.25 (0.09) 7.25 (0.08) 0.77
Hypoglycaemia 14/121 (11.5) 11/119 (9.2) 0.78 (0.34 – 1.79) 0.51
Apgar 5 min < 7 3 (2.3) 0 (0)
NNU admission  54 (42.2) 18 (12.6) 0.22 (0.12 – 0.41) <0.01 
Assisted ventilation 20 (14.5) 8 (5.6) 0.32 (0.14 – 0.76) <0.01 
NNU total days 268 (1.94) 152 (1.06) 0.07
NCAO 30 (21.7) 13 (9.1) 0.36 (0.18 – 0.72) <0.01 
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Table 5: Major interventions and outcomes stratified according to risk categories 
 Group 1 Group 2 OR (95%CI) P value 
Total babies 138 143  
High risk babies 81 (58.7) 69 (48.3)  
 n (%) / mean (SD) n (%) / mean (SD)  
Gestation 37.0 (1.3) 37.6 (1.2) 0.01 
Gestation >39 weeks 7 (8.6) 8 (11.6) 1.39 (0.48-4.04) 0.36 
Birthweight 2173 (294) 2355 (342) <0.01 
Spontaneous labour 3 (3.7) 11 (15.9) 4.93 (1.32-18.5) 0.01 
Induction 52 (64.2) 42 (60.9) 0.86 (0.45-1.68) 0.67 
Elective LSCS 23 (28.4) 14 (20.3) 0.64 (0.3-1.37) 0.25 
Emergency LSCS 18 (22.2) 9 (13.0) 0.52 (0.21-1.26) 0.15 
NCAO 22 (27.2) 9 (13.0) 0.39 (0.16-0.92) 0.03 
NNU  38 (46.9) 16 (23.2) 0.34 (0.17-0.69) <0.01 
Low risk babies 57 (41.3) 74 (51.7)  
 n (%) / mean(SD) n (%) / mean (SD)  
Gestation 38.4 (1.17) 39.1 (1.25) <0.01 
Gestation >39 weeks 20 (35.1) 42 (56.8) 2.43 (1.19-4.95) 0.01 
Birthweight 2573 (237) 2720 (321) <0.01 
Spontaneous labour 9 (15.8) 34 (45.9) 4.53 (1.95-10.57) <0.01 
Induction 39 (68.4) 35 (47.3) 0.41 (0.20-0.85) 0.02 
Elective LSCS 8 (14.0) 3 (4.1) 0.26 (0.07-1.03) 0.06 
Emergency LSCS 6 (10.5) 9 (12.1) 1.18 (0.39-3.52) 0.77 
NCAO 8 (14.0) 4 (5.4) 0.35 (0.10-1.23) 0.09 
NNU  16 (28.1) 2 (2.7) 0.07 (0.02-0.33) <0.01 
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